Titlebook: Radiotherapy in Prostate Cancer; Innovative Technique Hans Geinitz,Mack Roach III,Nicholas van As Book 2015 Springer-Verlag Berlin Heidelbe

中和

Techniques of Pelvic Irradiation,e cancer patients benefit from such treatment. Thus, the management of high risk and node-positive patients has evolved significantly in the past few years. New imaging tools such as MR, PET, and sentinel procedures now allow surgeons and radiation oncologists to better target lymph nodes or nodal m

排他

indoctrinate

Mutter

Hormonal Therapy and Radiation Therapy: Randomized and Prospective Trials,ting irradiation whatever its technique and destroying the infraclinical disease located outside the irradiated volume. Many phase III randomized trials have paved the way for establishing the indications of the combination of ADT with external irradiation. For locally advanced PCa, long-term ADT (≥

護(hù)身符

中子

Affiliation

Hypofractionation and Stereotactic Treatment: Clinical Data,diobiology has prompted a number of moderate as well as extreme hypofractionation trials using different treatment schedules with the aim of exploring the outcome and toxicity of shorter regimens. The hypofractionated regimes appear to be associated with excellent results and toxicity similar to tha

emulsify

Focal Therapy and the Index Lesion Hypothesis in Prostate Cancer,ve but has not been widely embraced. Focal therapy represents a middle ground between these two treatment options. In this paper we will review the rationale, patient selection considerations, technical planning issues, and recent clinical data for prostate focal therapy.

ALT

0942-5373 brachytherapy.Explores a range of current controversies in p.Today, the arsenal of “high-precision” or “targeted” radiotherapy includes a variety of techniques and approaches that, like the pieces of a puzzle, need to be put together to provide the prostate cancer patient with high-level optimized r

stratum-corneum

Overall- and Disease-Specific Survival in Prostata Cancer: Too Long to Wait?,necessary side effects and harms. It is up to the uro-oncologic community to encourage clinical randomised trials comparing radiotherapy with surgery to improve the disease-specific survival and overall outcome in these patients.